Founded in 1982, Leonhardt Ventures, located in Mission Viejo, CA, is a venture creation lab, product invention development laboratory, venture fund, and angels network. The Leonhardt team introduced the PolyCath line of cardiovascular balloon catheters in the 1980s, the TALENT (Taheri-Leonhardt) stent graft, StentValve, ProCell stem cell delivery catheters, PENSIL intravascular lung, RadiCath electromagnetic radiation delivery catheters, and bioelectric stimulators for improving blood flow in the 1990s. Since then, the primary focus has been on combining biologics and bioelectrics for organ regeneration, healing, and recovery. In 2001, the Leonhardt team led the first-ever non-surgical repair of a human heart with muscle stem cells. 35+ related innovations have been developed to date. More than 600,000 patients have benefited from the company's medical device and biotechnology innovations. See the portfolio of innovations, licensable technology platforms, and startups. The Leonhardt team has over 800 patent claims issued, pending, in process, optioned, or licensed.
| Website | http://www.leonhardtventures.com |
| Revenue | $14.2 million |
| Employees | View employees |
| Address | 12760 Millennium Dr Unit 213, Playa Vista, California 90094, US |
| Industry | Finance General, Finance |
| Competitors | Andreessen Horowitz, Sequoia Capital, General Catalyst, Bessemer Venture Partners, Insight Partners, Accel in India, Kleiner Perkins, New Enterprise Associates (NEA), Greylock, Benchmark +39 more (view full list) |
| SIC | SIC Code 628 Companies, SIC Code 62 Companies |
| NAICS | NAICS Code 52 Companies, NAICS Code 52393 Companies, NAICS Code 5239 Companies, NAICS Code 523 Companies |
Looking for a particular Leonhardt Ventures employee's phone or email?
The Leonhardt Ventures annual revenue was $14.2 million in 2026.
Leonhardt Ventures is based in Playa Vista, California.
The NAICS codes for Leonhardt Ventures are [52, 52393, 5239, 523].
The SIC codes for Leonhardt Ventures are [628, 62].